Trademark: DIGENESIS 2082209
Word
DIGENESIS
ID
2082209
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
17 April 2020
Registration Date
17 April 2020
Renewal Date
17 April 2030

Owner(s)
Service
Ellis Terry

Goods and Services:
Class 42:
Providing medical and scientific research information in the fields of medical research, pharmaceutical development and clinical trials; consulting services for others in the field of design and planning of clinical trials; consulting services for others in the fields of medical research and pharmaceutical development; consulting services for others in the fields of medical research and pharmaceutical development, namely, providing digital models of patients for use as simulated control subjects; consulting services for others in the field of design and planning of clinical trials, namely, providing digital models of patients for use as simulated control subjects for clinical trials; providing data analytics and artificial intelligence in the field of design and planning of clinicaltrials; providing data analytics and artificial intelligence in the fields ofmedical research and pharmaceutical development; providing data analytics and artificial intelligence in the life sciences field for the purpose of research, development, and commercialization; providing temporary use of on-line non-downloadable cloud computing software for managing, gathering, generating, organizing, and sharing data in the fields of pharmaceutical development, medical clinical trials and medical research; providing temporary use of on-line non-downloadable cloud computing software for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols; providing temporary use of on-line non-downloadable cloud computing software for designing, managing, and executing pharmaceutical development research; hosting a website featuring educational information in the fields of medical research, pharmaceutical development, clinical trials and artificial intelligence